Publications by authors named "S Viteri"

Claim this Profile
K
KRAS Mutation Status in Non-Small Cell Lung Cancer Distribution Across Occupational Categories.
Roberto Serna-Blasco, Karla Medina, María Ángeles Sala, David Aguiar, Asunción Díaz-Serrano, Santiago Viteri

Chest· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of Early Epinephrine with Hemodynamics and Outcome in Pediatric In-Hospital Cardiac Arrest: A Secondary Analysis of a Multicenter, Cluster-randomized Clinical Trial Intensive Care Unit Resuscitation (ICU-RESUS).
Ashley Siems, Maryam Y Naim, Robert A Berg, Ron W Reeder, Tageldin Ahmed, Shirley Viteri

Ann Am Thorac Soc· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intracranial and systemic progression on amivantamab in platinum-treated epidermal growth factor receptor exon 20 insertion-mutated advanced non-small cell lung cancer.
Natasha B Leighl, Jose Trigo, Keunchil Park, Se-Hoon Lee, Nicolas Girard, Santiago Viteri

Lung Cancer· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive molecular profiling of advanced NSCLC using NGS: Prevalence of druggable mutations and clinical trial opportunities in the ATLAS study.
Roberto Serna-Blasco, Pilar Mediavilla-Medel, Karla Medina, María Ángeles Sala, David Aguiar, Santiago Viteri

Lung Cancer· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ARTEMIA phase 3 study: A randomized, open-label trial comparing the efficacy and safety of OSE2101 versus docetaxel in HLA-A2 positive patients with metastatic non-small cell lung cancer and secondary resistance to immune checkpoint inhibitors.
S V Liu, R Dziadziuszko, S Viteri, F Cappuzzo, S Comis

Lung Cancer· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis